Methyl-d3-magnesium Iodide is used as a reagent in the synthesis of Anacetrapib-d3 (A637202); a labelled orally active and potent cholesterol ester transfer protein (CETP) inhibitor for the treatment of atherosclerosis, in particular dyslipidemia.
Compounds Can Strictly Be Provided For Research And Development Purposes. Compounds Are Not Intended For Animal/Human Testing And/Or Usage